Respiratory viral RNA on toys in pediatric office waiting rooms

Diane E Pappas1, J Owen Hendley, Richard H Schwartz

  • 1Department of Pediatrics, University of Virginia Health System, Charlottesville, VA 22908, USA. dep6b@virginia.edu

Abstract

Insights

Pediatric office toys can harbor respiratory viruses like picornavirus. Cleaning toys with disinfectant cloths showed modest effectiveness in reducing viral RNA contamination.

Area of Science:

  • Pediatric infectious disease
  • Environmental virology
  • Public health

Background:

  • Toys in pediatric waiting rooms can act as fomites for virus transmission.
  • Understanding viral contamination on toys is crucial for infection control in healthcare settings.

Purpose of the Study:

  • To investigate the prevalence of respiratory viruses on toys in pediatric office waiting rooms.
  • To assess the effectiveness of cleaning protocols and potential for viral transfer.

Main Methods:

  • Samples were collected from toys in sick and well waiting rooms on multiple occasions.
  • Polymerase chain reaction (PCR) was used to detect picornavirus, respiratory syncytial virus, and influenza viruses.
  • Toy surface and finger sampling were conducted before and after cleaning procedures.

Main Results:

  • Viral RNA was detected on 21% of sampled toys, with picornavirus being the most common.
  • Toys in sick waiting rooms showed higher contamination rates (20%) compared to well waiting rooms (17%).
  • Cleaning reduced viral RNA on toys, but contamination persisted; viral transfer to fingers was inefficient.

Conclusions:

  • Approximately 20% of toys in pediatric offices may be contaminated with respiratory viral RNA.
  • Disinfectant cloth cleaning offers only moderate effectiveness in removing viral RNA from toy surfaces.
  • While toys can be contaminated, direct transfer of picornaviral RNA to fingers appears to be inefficient.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in various...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...